Brief: Crescita Therapeutics names Muneerah Kanji as interim CFO
10/02/2017 12:30
Feb 10 (Reuters) - Crescita Therapeutics Inc CTX.TO
* Crescita Therapeutics announces management and board
changes
* Crescita Therapeutics Inc - Muneerah Kanji has assumed
role of interim chief financial officer
* Crescita Therapeutics Inc- Crescita has commenced a formal
search process for a new chief financial officer
* Crescita Therapeutics Inc - Kanji replacing Mario Laflamme
Source text for Eikon: ID:nCNWBRmVba
Further company coverage: CTX.TO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium